Organon (OGN) Prices $1B Notes Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Organon Announces Pricing of $1.0 Billion Senior Notes Offering
May 7, 2024 8:20 PM EDTJERSEY CITY, N.J.--(BUSINESS WIRE)-- Organon (NYSE: OGN) (Organon), a global healthcare company with a focus on womens health, announced today that it, together with Organon Foreign Debt Co-Issuer B.V., a direct wholly-owned subsidiary of Organon, as co-issuer (the Co-Issuer and, together with Organon, the Companies), have priced an offering of $500 million of 6.750% senior secured notes due 2034 (the Secured Notes) and $500 million of 7.875% senior unsecured notes due 2034 (the Unsecured Notes and, together with the Secured Notes the Notes). Each series of notes will be guaranteed by each of the entities that guarantees the Companies existing... More
